Sena Kim, PhD

Medical School Department Internal Medicine
Research Program Hematopoietic Development & Malignancy
Sena Kim

Researcher Background

Primary Academic Title

Instructor, Department of Medicine, Division of Oncology, WashU Medicine

Training

  • 2016 - 2018: PostDoc Research Fellow, Department of Biological Science, University of Ulsan, South Korea
  • 2018 - 2022: PostDoc Research Associate, Department of Transplant Immunology, Washington University School of Medicine, St. Louis, MO

Education

  • 2011: BS, University of Ulsan, South Korea
  • 2016: MS/PhD, University of Ulsan, South Korea

Research & Selected Publications

Research Interest

My research interest is to optimize allo-HSCT for the treatment of hematopoietic malignancies. The therapeutic benefits of allo-HSCT derive from the GvL effect that is mediated by mature T cells present in the donor graft. Unfortunately, the same donor T cells can also cause GvHD, which remains a major barrier to the success of allo-HSCT. Thus, identification of molecular targets could be pivotal in developing therapeutics to eliminate GvHD while enhancing GvL.

Research Publications

BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation.
Authors:

Kim S, Dania AJ, Lim S, Choi J

Journal & Year:

Molecules • 2025

Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model.
Authors:

Kim S, Ruminski P, Singh M, one or more additional authors omitted Choi J

Journal & Year:

Molecules • 2024